Research Article
BibTex RIS Cite

Bruselloz hastalarında serum YKL-40 düzeylerinin belirlenmesi

Year 2019, , 335 - 339, 30.09.2019
https://doi.org/10.18663/tjcl.472868

Abstract

Amaç: Bruselloz tanılı hastalarda serum
YKL-40 düzeylerini belirlemek.



Gereç ve Yöntemler: Bu çalışmaya serum
aglütinasyon testi pozitif 40 Bruselloz hastası ve 41 sağlıklı kontrol grubu dahil
edilmiştir. İki grup arasında serum YKL-40, hematolojik parametreler ve C
reaktif protein (CRP) değerleri karşılaştırılmıştır.



Bulgular: Bruselloz hasta grubunda, YKL-40 değeri 15.0 ± 8.8 ng/mL, CRP 0.2 ± 0.1 mg/dL,
Nötrofil/ Lenfosit oranı (NLR) 1.5 ± 1.0 ve Platelet/Lenfosit oranı (PLR) 109.3
± 46.4 idi.
Kontrol grubunda, YKL-40 değeri 12.7 ± 6.1ng/mL, CRP 1.48 ±
2.1mg/dL, Nötrofil/ Lenfosit oranı (NLR) 2.1 ± 0.7 ve Platelet/Lenfosit oranı
(PLR) 147.8 ± 59.0 idi.



Sonuç: YKL-40 düzeylerinde hasta ve
kontrol grubu arasında anlamlı bir fark bulunmamıştır. Hasta grubunda kontrol
grubuna göre CRP anlamlı olarak yüksek, bunun yanında YKL-40 ile CRP, PLT, PLR,
NLR ve yaş arasında pozitif korelasyon saptanmıştır. Ancak YKL-40’ ın
enfeksiyon hastalıklarında rolünün daha iyi anlaşılabilmesi için ileri
çalışmalara ihtiyaç vardır.

References

  • 1. EJ Y. Brucella species. In: Mandell GL, Bennet JE, Dolin R, (eds). Principles and Practice of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2005: 2669-72.
  • 2. Hussein MZ, Abou-Elnoeman SA, Al-Fikky AA, El-Samadouny EI, Shaaban AAM. Evaluation of Rose Bengal Test, Standard Tube Agglutination Test and Nested PCR for the diagnosis of Human Brucellosis. Egypt J Med Microbiol 2006; 15: 249-56.
  • 3. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010; 140: 392-8.
  • 4. Galinska EM, Zagorski J. Brucellosis in humans-etiology, diagnostics, clinical forms, Ann Agric Environ Med 2013; 20: 233–38.
  • 5. Hekmatimoghaddam S, Sadeh M, Khalili MB, Mollaabedin M, Sazmand A. Comparison of PCR, Wright agglutination test and blood culture for diagnosis of brucellosis in suspected patients. Pak J Biol Sci 2013; 16: 1589–92.
  • 6. Gomez MC, Nieto JA, Rosa C, Geijo P et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008; 15: 1031-33.
  • 7. Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia. J Infect Public Health 2012; 5: 189-94.
  • 8. Olt S, Ergenc H, Acikgoz SB. Predictive contribution of neutrophil/lymphocyte ratio in diagnosis of brucellosis. Biomed Res Int 2015; 2015: 210502.
  • 9. Łata E, Gisterek I, Matkowski R, Szelachowska J, Kornafel J. The importance of determining the prognostic marker YKL-40 in serum and tissues. Pol Merkur Lekarski 2010; 28: 505-8.
  • 10. Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009; 511: 159-84.
  • 11. Libreros S, Iragavarapu-Charyulu V. YKL-40/CHI3L1 drives inflammation on the road of tumor progression. J Leukoc Biol 2015; 98: 931-36.
  • 12. Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40- neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011; 10: 742-51.
  • 13. Volck B, Johansen JS, Stoltenberg M et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001; 9: 203–14.
  • 14. Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters. Clin Exp Rheumatol 2001: 19; 655–60.
  • 15. Vind I, Johansen, JS, Price PA, Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 2003; 38: 599–605.
  • 16. Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, et al. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 2003; 18: 254–59.
  • 17. Kronborg G, Ostergaard C, Weis N et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002; 34: 323–26.
  • 18. Hattori N, Oda S, Sadahiro T et al. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 2009; 32: 393–400.
  • 19. Ostergaard C, Johansen JS, Benfield T, Pric PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002; 9: 598–604.
  • 20. Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 2002; 90: 281–97.
  • 21. Fernandes DM, Baldwin CL. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 1995; 63: 1130–33.
  • 22. Xavier MN, Winter MG, Spees AM et al. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLOS Pathog 2013; 9: 1003454.
  • 23. Volck B, Price PA, Johansen JS et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998; 110: 351–60.
  • 24. Johansen JS, Møller S, Price PA et al. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol 1997; 32: 582–90.
  • 25. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268: 25803–10.
  • 26. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997; 237: 46–54.
  • 27. Bozdemir ŞE, Altıntop YA, Uytun S, Aslaner H, Torun YA. Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis. Korean J Intern Med 2017; 32: 1075-81.

Determination of serum YKL-40 levels in patients with brucellosis

Year 2019, , 335 - 339, 30.09.2019
https://doi.org/10.18663/tjcl.472868

Abstract


Aim:
To determine serum YKL-40 levels in patients diagnosed with
brucellosis.


Material
and Methods:
This study included 40 Brucellosis patients with
positive serum agglutination tests and 41 healthy control subjects.
The two groups were compared with regard to their serum YKL-40,
hematological parameters, and C-reactive protein (CRP) values.


Results:
The brucellosis patient group presented YKL-40 values of 15.0 ± 8.8
ng/mL, CRP values of 0.2 ± 0.1 mg/dL, a Neutrophil/Lymphocyte ratio
(NLR) of 1.5 ± 1.0, and a Platelet/Lymphocyte ratio (PLR) of 109.3 ±
46.4. The control group presented YKL-40 values of 12.7 ± 6.1ng/mL,
CRP values of 1.48 ± 2.1mg/dL, a Neutrophil/Lymphocyte ratio (NLR)
of 2.1 ± 0.7, and a Platelet/Lymphocyte ratio (PLR) of 147.8 ±
59.0.





Conclusion:
No significant differences were determined between the YKL-40 levels
of the patient and control groups. The patient group manifested
significantly higher levels of CRP compared to the control group, and
YKL-40 was determined to be positively correlated with CRP, PLT, PLR,
NLR and age. However, further studies are needed for the role of
YKL-40 in infectious diseases to be understood more clearly.

References

  • 1. EJ Y. Brucella species. In: Mandell GL, Bennet JE, Dolin R, (eds). Principles and Practice of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2005: 2669-72.
  • 2. Hussein MZ, Abou-Elnoeman SA, Al-Fikky AA, El-Samadouny EI, Shaaban AAM. Evaluation of Rose Bengal Test, Standard Tube Agglutination Test and Nested PCR for the diagnosis of Human Brucellosis. Egypt J Med Microbiol 2006; 15: 249-56.
  • 3. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010; 140: 392-8.
  • 4. Galinska EM, Zagorski J. Brucellosis in humans-etiology, diagnostics, clinical forms, Ann Agric Environ Med 2013; 20: 233–38.
  • 5. Hekmatimoghaddam S, Sadeh M, Khalili MB, Mollaabedin M, Sazmand A. Comparison of PCR, Wright agglutination test and blood culture for diagnosis of brucellosis in suspected patients. Pak J Biol Sci 2013; 16: 1589–92.
  • 6. Gomez MC, Nieto JA, Rosa C, Geijo P et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008; 15: 1031-33.
  • 7. Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia. J Infect Public Health 2012; 5: 189-94.
  • 8. Olt S, Ergenc H, Acikgoz SB. Predictive contribution of neutrophil/lymphocyte ratio in diagnosis of brucellosis. Biomed Res Int 2015; 2015: 210502.
  • 9. Łata E, Gisterek I, Matkowski R, Szelachowska J, Kornafel J. The importance of determining the prognostic marker YKL-40 in serum and tissues. Pol Merkur Lekarski 2010; 28: 505-8.
  • 10. Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009; 511: 159-84.
  • 11. Libreros S, Iragavarapu-Charyulu V. YKL-40/CHI3L1 drives inflammation on the road of tumor progression. J Leukoc Biol 2015; 98: 931-36.
  • 12. Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40- neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011; 10: 742-51.
  • 13. Volck B, Johansen JS, Stoltenberg M et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001; 9: 203–14.
  • 14. Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters. Clin Exp Rheumatol 2001: 19; 655–60.
  • 15. Vind I, Johansen, JS, Price PA, Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 2003; 38: 599–605.
  • 16. Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, et al. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 2003; 18: 254–59.
  • 17. Kronborg G, Ostergaard C, Weis N et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002; 34: 323–26.
  • 18. Hattori N, Oda S, Sadahiro T et al. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 2009; 32: 393–400.
  • 19. Ostergaard C, Johansen JS, Benfield T, Pric PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002; 9: 598–604.
  • 20. Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 2002; 90: 281–97.
  • 21. Fernandes DM, Baldwin CL. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 1995; 63: 1130–33.
  • 22. Xavier MN, Winter MG, Spees AM et al. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLOS Pathog 2013; 9: 1003454.
  • 23. Volck B, Price PA, Johansen JS et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998; 110: 351–60.
  • 24. Johansen JS, Møller S, Price PA et al. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol 1997; 32: 582–90.
  • 25. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268: 25803–10.
  • 26. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997; 237: 46–54.
  • 27. Bozdemir ŞE, Altıntop YA, Uytun S, Aslaner H, Torun YA. Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis. Korean J Intern Med 2017; 32: 1075-81.
There are 27 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Orıgınal Artıcle
Authors

Fikriye Milletli Sezgin 0000-0002-8317-2312

Rukiye Nar

Publication Date September 30, 2019
Published in Issue Year 2019

Cite

APA Milletli Sezgin, F., & Nar, R. (2019). Determination of serum YKL-40 levels in patients with brucellosis. Turkish Journal of Clinics and Laboratory, 10(3), 335-339. https://doi.org/10.18663/tjcl.472868
AMA Milletli Sezgin F, Nar R. Determination of serum YKL-40 levels in patients with brucellosis. TJCL. September 2019;10(3):335-339. doi:10.18663/tjcl.472868
Chicago Milletli Sezgin, Fikriye, and Rukiye Nar. “Determination of Serum YKL-40 Levels in Patients With Brucellosis”. Turkish Journal of Clinics and Laboratory 10, no. 3 (September 2019): 335-39. https://doi.org/10.18663/tjcl.472868.
EndNote Milletli Sezgin F, Nar R (September 1, 2019) Determination of serum YKL-40 levels in patients with brucellosis. Turkish Journal of Clinics and Laboratory 10 3 335–339.
IEEE F. Milletli Sezgin and R. Nar, “Determination of serum YKL-40 levels in patients with brucellosis”, TJCL, vol. 10, no. 3, pp. 335–339, 2019, doi: 10.18663/tjcl.472868.
ISNAD Milletli Sezgin, Fikriye - Nar, Rukiye. “Determination of Serum YKL-40 Levels in Patients With Brucellosis”. Turkish Journal of Clinics and Laboratory 10/3 (September 2019), 335-339. https://doi.org/10.18663/tjcl.472868.
JAMA Milletli Sezgin F, Nar R. Determination of serum YKL-40 levels in patients with brucellosis. TJCL. 2019;10:335–339.
MLA Milletli Sezgin, Fikriye and Rukiye Nar. “Determination of Serum YKL-40 Levels in Patients With Brucellosis”. Turkish Journal of Clinics and Laboratory, vol. 10, no. 3, 2019, pp. 335-9, doi:10.18663/tjcl.472868.
Vancouver Milletli Sezgin F, Nar R. Determination of serum YKL-40 levels in patients with brucellosis. TJCL. 2019;10(3):335-9.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.